tiprankstipranks
Trending News
More News >
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market

Marvel Biosciences Corp (MRVL) Income Statement

Compare
40 Followers

Marvel Biosciences Corp Income Statement

Last quarter (Q1 2026), Marvel Biosciences Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Marvel Biosciences Corp's net income was C$-342.26K. See Marvel Biosciences Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -547.37KC$ 0.00C$ -887.52KC$ -1.38MC$ -613.10K
Operating Expenses
C$ 701.32KC$ 1.22KC$ 2.32MC$ 1.17MC$ 485.04K
Depreciation and Amortization
C$ 0.00C$ 1.22KC$ 66.92KC$ 152.00C$ 185.00
EBITDA
C$ -1.94MC$ -1.54MC$ -2.25MC$ -2.55MC$ -1.25M
Operating Income
C$ -1.25MC$ -1.22KC$ -2.32MC$ -2.54MC$ 806.33K
Other Income/Expenses
C$ -962.78KC$ -425.00C$ 27.54KC$ -5.86KC$ -1.79M
Pretax Income
C$ -2.21MC$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04M
Net Income
C$ -2.21MC$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04M
Per Share Metrics
Basic EPS
C$ -0.05C$ -41.30C$ -0.06C$ -0.08C$ -0.09
Diluted EPS
C$ -0.05C$ -41.30C$ -0.06C$ -0.08C$ -0.09
Weighted Average Shares Outstanding
47.30M 39.96M 39.66M 32.76M 32.59M
Weighted Average Shares Outstanding (Diluted)
47.30M 39.96M 39.66M 32.76M 32.59M
Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History